Rapid identification of mutations in a multidrug efflux pump in Pseudomonas aeruginosa

被引:17
作者
Jalal, S
Wretlind, G
Gotoh, N
Wretlind, B
机构
[1] Huddinge Univ Hosp, Div Clin Bacteriol, S-14186 Huddinge, Sweden
[2] Kyoto Pharmaceut Univ, Dept Microbiol, Kyoto 607, Japan
关键词
NIRCA; PCR; multidrug efflux pump; antibiotic resistance;
D O I
10.1111/j.1699-0463.1999.tb01516.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The gene mexR regulates negatively the expression of the MexA-MexB-OprM efflux pump in Pseudomonas aeruginosa, and mutations in mexR cause a multiple antibiotic resistance phenotype. Five hundred and forty resistant clones of P. aeruginosa PAO503 were isolated after selection for resistance to chloramphenicol or tetracycline. All isolates showed similar phenotypes and were resistant to tetracycline, chloramphenicol and norfloxacin. Nineteen randomly selected isolates were analyzed. Since mutational analysis by direct sequencing of all regions of interest in several strains is time-consuming and expensive, a screening method, Non-Isotopic RNase Cleavage Assay (NIRCA(TM)), was applied to identify mutant genes so that they could be targeted for DNA sequencing. NIRCA is a simple but rapid method for mutational analysis and can be performed in 3-4 h. Results of NIRCA analysis were compared with DNA sequencing. Both NIRCA and DNA sequencing analysis showed mexR gene mutations in 11 of 19 isolates but no alterations in 8 strains. An immunoblot assay showed overexpression of OprN, a component of another multidrug efflux pump, MexE-MexF-OprN, in those eight isolates. Nucleotide sequencing of quinolone resistance-determining regions of DNA gyrase (gyrA) or topoisomerase IV (parC) showed no alterations in any of the 19 mutants. The data indicate that two efflux pump systems, MexA-MexB-OprM and MexE-MexF-OprN, were involved in multidrug resistance including quinolones and that NIRCA is a sensitive method for screening mutations.
引用
收藏
页码:1109 / 1116
页数:8
相关论文
共 21 条
[1]   NFXC-TYPE QUINOLONE RESISTANCE IN A CLINICAL ISOLATE OF PSEUDOMONAS-AERUGINOSA [J].
FUKUDA, H ;
HOSAKA, M ;
IYOBE, S ;
GOTOH, N ;
NISHINO, T ;
HIRAI, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (03) :790-792
[2]  
Goldrick MM, 1996, BIOTECHNIQUES, V21, P106
[3]   Functional replacement of OprJ by OprM in the MexCD-OprJ multidrug efflux system of Pseudomonas aeruginosa [J].
Gotoh, N ;
Tsujimoto, H ;
Nomura, A ;
Okamoto, K ;
Tsuda, M ;
Nishino, T .
FEMS MICROBIOLOGY LETTERS, 1998, 165 (01) :21-27
[4]   Characterization of the MexC-MexD-OprJ multidrug efflux system in ΔmexA-mexB-oprM mutants of Pseudomonas aeruginosa [J].
Gotoh, N ;
Tsujimoto, H ;
Tsuda, M ;
Okamoto, K ;
Nomura, A ;
Wada, T ;
Nakahashi, M ;
Nishino, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (08) :1938-1943
[5]  
Haseyama K, 1998, J MED VIROL, V56, P205
[7]   PURIFICATION OF A 54-KILODALTON PROTEIN (OPRJ) PRODUCED IN NFXB MUTANTS OF PSEUDOMONAS-AERUGINOSA AND PRODUCTION OF A MONOCLONAL-ANTIBODY SPECIFIC TO OPRJ [J].
HOSAKA, M ;
GOTOH, N ;
NISHINO, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (08) :1731-1735
[8]   Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa [J].
Jalal, S ;
Wretlind, B .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1998, 4 (04) :257-261
[9]   Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa [J].
Kohler, T ;
MicheaHamzehpour, M ;
Henze, U ;
Gotoh, N ;
Curty, LK ;
Pechere, JC .
MOLECULAR MICROBIOLOGY, 1997, 23 (02) :345-354
[10]   PRE-BOILING HIGH GC CONTENT, MIXED PRIMERS WITH 3' COMPLEMENTATION ALLOWS THE SUCCESSFUL PCR AMPLIFICATION OF PSEUDOMONAS-AERUGINOSA DNA [J].
KUREISHI, A ;
BRYAN, LE .
NUCLEIC ACIDS RESEARCH, 1992, 20 (05) :1155-1155